Plasma levels of adrenomedullin, a newly identified hypotensive peptide, in patients with hypertension and renal failure.
Toshihiko Ishimitsu(Dokkyo Medical University), H Matsuoka(National Cerebral and Cardiovascular Center), Yoshihiko Saito(National Archives and Records Administration), Kenji Kangawa(National Cerebral and Cardiovascular Center), Kazuo Kitamura(University of Miyazaki), T Omae(National Cerebral and Cardiovascular Center), H. Matsuo(Kyoto University), Tanenao Eto(University of Miyazaki), Toshio Nishikimi(Kyoto University)
Cited by 478
Related Papers
Erratum: The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2009)
|Hypertension Research|2014|1.4k
Plasma Brain Natriuretic Peptide as a Prognostic Indicator in Patients With Primary Pulmonary Hypertension
|Circulation|2000|880
Plasma Brain Natriuretic Peptide Levels Increase in Proportion to the Extent of Right Ventricular Dysfunction in Pulmonary Hypertension
|Journal of the American College of Cardiology|1998|578
The role of natriuretic peptides in cardioprotection
|Cardiovascular Research|2005|483
Increased plasma levels of adrenomedullin in patients with heart failure
|Journal of the American College of Cardiology|1995|307